Reportedly, D2R agonists are shown to significantly reduce the activation of astrocytes and the release of TNF-α in the spinal cord of a mouse model of amyotrophic lateral sclerosis and also prevent motor neuron loss (or death). Here, DRD2 is linked to amyotrophic lateral sclerosis.